155 related articles for article (PubMed ID: 10669851)
1. The role of IL-12 in the induction of late-phase cellular infiltration in a murine model of allergic conjunctivitis.
Magone MT; Whitcup SM; Fukushima A; Chan CC; Silver PB; Rizzo LV
J Allergy Clin Immunol; 2000 Feb; 105(2 Pt 1):299-308. PubMed ID: 10669851
[TBL] [Abstract][Full Text] [Related]
2. Role of interferon-gamma in a mouse model of allergic conjunctivitis.
Stern ME; Siemasko K; Gao J; Duong A; Beauregard C; Calder V; Niederkorn JY
Invest Ophthalmol Vis Sci; 2005 Sep; 46(9):3239-46. PubMed ID: 16123425
[TBL] [Abstract][Full Text] [Related]
3. The Th1/Th2 paradigm in ocular allergy.
Stern ME; Siemasko KF; Niederkorn JY
Curr Opin Allergy Clin Immunol; 2005 Oct; 5(5):446-50. PubMed ID: 16131922
[TBL] [Abstract][Full Text] [Related]
4. Roles of OX40 in the development of murine experimental allergic conjunctivitis: exacerbation and attenuation by stimulation and blocking of OX40.
Fukushima A; Yamaguchi T; Ishida W; Fukata K; Yagita H; Ueno H
Invest Ophthalmol Vis Sci; 2006 Feb; 47(2):657-63. PubMed ID: 16431965
[TBL] [Abstract][Full Text] [Related]
5. Endogenous IL-12 is required for induction and expression of experimental autoimmune uveitis.
Tarrant TK; Silver PB; Chan CC; Wiggert B; Caspi RR
J Immunol; 1998 Jul; 161(1):122-7. PubMed ID: 9647215
[TBL] [Abstract][Full Text] [Related]
6. Systemic overexpression of IFN-gamma and IL-5 exacerbates early phase reaction and conjunctival eosinophilia, respectively, in experimental allergic conjunctivitis.
Ishida W; Tsuru E; Tominaga A; Miyazaki JI; Higuchi T; Sakamoto S; Fukushima A
Br J Ophthalmol; 2009 Dec; 93(12):1680-5. PubMed ID: 19692377
[TBL] [Abstract][Full Text] [Related]
7. Endogenous IFN-gamma and IL-18 production directly limit induction of type 2 immunity in vivo.
Lewkowich IP; HayGlass KT
Eur J Immunol; 2002 Dec; 32(12):3536-45. PubMed ID: 12442336
[TBL] [Abstract][Full Text] [Related]
8. Systemic or mucosal administration of immunostimulatory DNA inhibits early and late phases of murine allergic conjunctivitis.
Magone MT; Chan CC; Beck L; Whitcup SM; Raz E
Eur J Immunol; 2000 Jul; 30(7):1841-50. PubMed ID: 10940873
[TBL] [Abstract][Full Text] [Related]
9. IFN-gamma-inducing factor (IL-18) increases allergic sensitization, serum IgE, Th2 cytokines, and airway eosinophilia in a mouse model of allergic asthma.
Wild JS; Sigounas A; Sur N; Siddiqui MS; Alam R; Kurimoto M; Sur S
J Immunol; 2000 Mar; 164(5):2701-10. PubMed ID: 10679111
[TBL] [Abstract][Full Text] [Related]
10. [Roles of cytokines in the development of severe allergic conjunctival diseases: analyses using animal models].
Fukushima A
Nippon Ganka Gakkai Zasshi; 2004 Nov; 108(11):682-9. PubMed ID: 15584353
[TBL] [Abstract][Full Text] [Related]
11. Endogenous IL-12 is required for control of Th2 cytokine responses capable of exacerbating leishmaniasis in normally resistant mice.
Heinzel FP; Rerko RM; Ahmed F; Pearlman E
J Immunol; 1995 Jul; 155(2):730-9. PubMed ID: 7608551
[TBL] [Abstract][Full Text] [Related]
12. IL-27 signaling deficiency develops Th17-enhanced Th2-dominant inflammation in murine allergic conjunctivitis model.
Chen X; Deng R; Chi W; Hua X; Lu F; Bian F; Gao N; Li Z; Pflugfelder SC; de Paiva CS; Li DQ
Allergy; 2019 May; 74(5):910-921. PubMed ID: 30515838
[TBL] [Abstract][Full Text] [Related]
13. Topical Administration of β-1,3-Glucan to Modulate Allergic Conjunctivitis in a Murine Model.
Lee HS; Kwon JY; Joo CK
Invest Ophthalmol Vis Sci; 2016 Mar; 57(3):1352-60. PubMed ID: 27002295
[TBL] [Abstract][Full Text] [Related]
14. Fyn regulates eosinophil infiltration into the conjunctiva by downregulating the Th2 response.
Fukushima A; Yamaguchi T; Ozaki A; Taniguchi T; Udaka K; Ueno H
Graefes Arch Clin Exp Ophthalmol; 2005 Oct; 243(10):1043-9. PubMed ID: 15838661
[TBL] [Abstract][Full Text] [Related]
15. Participation of CD11b and F4/80 molecules in the conjunctival eosinophilia of experimental allergic conjunctivitis.
Fukushima A; Ishida W; Ojima A; Kajisako M; Sumi T; Yamada J; Tsuru E; Miyazaki J; Tominaga A; Yagita H
Int Arch Allergy Immunol; 2010; 151(2):129-36. PubMed ID: 19752566
[TBL] [Abstract][Full Text] [Related]
16. Endogenous interleukin-10 produced by antigen-irrelevant cells promotes the development of experimental murine allergic conjunctivitis.
Fukushima A; Sumi T; Fukuda K; Kumagai N; Nishida T; Ueno H
Int Arch Allergy Immunol; 2007; 144(1):79-84. PubMed ID: 17505142
[TBL] [Abstract][Full Text] [Related]
17. Allergen-mediated modulation of CD23 expression is interferon-gamma and interleukin-10 dependent in allergic and non-allergic individuals.
Roever AC; Heine G; Zuberbier T; Worm M
Clin Exp Allergy; 2003 Nov; 33(11):1568-75. PubMed ID: 14616870
[TBL] [Abstract][Full Text] [Related]
18. Notch ligand Delta-like4 inhibits the development of murine experimental allergic conjunctivitis.
Fukushima A; Sumi T; Ishida W; Ojima A; Kajisako M; Koyanagi A; Koyama N; Yagita H
Immunol Lett; 2008 Dec; 121(2):140-7. PubMed ID: 19027794
[TBL] [Abstract][Full Text] [Related]
19. Curcumin suppresses ovalbumin-induced allergic conjunctivitis.
Chung SH; Choi SH; Choi JA; Chuck RS; Joo CK
Mol Vis; 2012; 18():1966-72. PubMed ID: 22876123
[TBL] [Abstract][Full Text] [Related]
20. Suppression of antigen-specific T- and B-cell responses by intranasal or oral administration of recombinant bet v 1, the major birch pollen allergen, in a murine model of type I allergy.
Wiedermann U; Jahn-Schmid B; Bohle B; Repa A; Renz H; Kraft D; Ebner C
J Allergy Clin Immunol; 1999 Jun; 103(6):1202-10. PubMed ID: 10359907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
